AsterInsights (@asterinsights) 's Twitter Profile
AsterInsights

@asterinsights

Accelerating oncology medical product discovery and development through our scientific and clinical intelligence.

ID: 1124317926746669056

linkhttps://www.asterinsights.com/ calendar_today03-05-2019 14:20:57

773 Tweet

238 Followers

438 Following

Roswell Park (@roswellpark) 's Twitter Profile Photo

Chief Fellow ⁦Riya Patel, MD⁩ proudly sharing her research with Dr. Renuka Iyer at #ASCO24. Using ORIEN data, they uncovered likely biomarkers that can indicate which patients with #cholangiocarcinoma will benefit most from #immunotherapy.

Chief Fellow ⁦<a href="/patel_riya7/">Riya Patel, MD</a>⁩ proudly sharing her research with Dr. Renuka Iyer at #ASCO24. Using ORIEN data, they uncovered likely biomarkers that can indicate which patients with #cholangiocarcinoma will benefit most from #immunotherapy.
Moffitt Cancer Center (@moffittnews) 's Twitter Profile Photo

Ahmad Tarhini, MD, PhD (Ahmad Tarhini) presented on how immune cell state atlas can predict the benefits of ICIs in #melanoma treatment. #MoffittASCO24 Learn more: bit.ly/4bRZRrn #ASCO24 ASCO

AsterInsights (@asterinsights) 's Twitter Profile Photo

Today at #ASCO24, Dr. Taylor Rives, Markey Cancer Center, presents collaborative #ORIEN research about molecular differences in Kentucky Appalachian populations which may reveal opportunities for treatment and reduce #cancer disparities. More: meetings.asco.org/abstracts-pres… #CollaborativeScience

Today at #ASCO24, Dr. Taylor Rives, <a href="/UKMarkey/">Markey Cancer Center</a>, presents collaborative #ORIEN research about molecular differences in Kentucky Appalachian populations which may reveal opportunities for treatment and reduce #cancer disparities. More: meetings.asco.org/abstracts-pres… #CollaborativeScience
Markey Cancer Center (@ukmarkey) 's Twitter Profile Photo

GYN oncology fellow, Taylor A. Rives, MD, MD found there are genomic differences in #EndometrialCancer of non-Appalachian & Appalachian patients with increased EVI5 mutations, an oncogene in cell cycle regulation. #ASCO24 Markey Cancer Center

GYN oncology fellow, <a href="/TaylorARives/">Taylor A. Rives, MD</a>, MD found there are genomic differences in #EndometrialCancer of non-Appalachian &amp; Appalachian patients with increased EVI5 mutations, an oncogene in cell cycle regulation. #ASCO24 <a href="/UKMarkey/">Markey Cancer Center</a>
AsterInsights (@asterinsights) 's Twitter Profile Photo

In June, we recognize the strength and resilience of cancer survivors. We celebrate life, spread hope, and continue our commitment to #CancerResearch to improve outcomes for all. Learn from survivors Barney Morris and Deb Collyar why they advocate for patients & cancer research.

Ahmad Tarhini (@atarhinimdphd) 's Twitter Profile Photo

Excited to share our latest published article | Differences in Co-Expression of #TCell #CoInhibitory & #CoStimulatory Molecules with #PD1 Across Different Human Cancers | #Immunooncology #DrugDevelopment #ORIEN Moffitt Cancer CenterMoffitt Research⁩ gavinpublishers.com/article/view/d…

Excited to share our latest published article | Differences in Co-Expression of #TCell #CoInhibitory &amp; #CoStimulatory Molecules with #PD1 Across Different Human Cancers | #Immunooncology #DrugDevelopment #ORIEN <a href="/MoffittNews/">Moffitt Cancer Center</a> ⁦<a href="/MoffittResearch/">Moffitt Research</a>⁩

gavinpublishers.com/article/view/d…
NCI Cancer Control (@ncicancerctrl) 's Twitter Profile Photo

The National Cancer Institute Division of Cancer Control & Population Sciences welcomes Dr. Erin Siegel as the new Associate Director of our Epidemiology & Genomics Research Program! Learn more about Dr. Siegel here: epi.grants.cancer.gov/staff/siegel.h…

The <a href="/theNCI/">National Cancer Institute</a> Division of Cancer Control &amp; Population Sciences welcomes Dr. Erin Siegel as the new Associate Director of our Epidemiology &amp; Genomics Research Program! Learn more about Dr. Siegel here: epi.grants.cancer.gov/staff/siegel.h…
AsterInsights (@asterinsights) 's Twitter Profile Photo

Uncover new targets & biomarkers, accelerate clinical trials & more, w/the deepest multimodal dataset for #OncologyResearch & development. • Longitudinal lifetime-consented clinical data • Tumor & Germline DNA • Tumor RNA • Digital pathology ow.ly/hswq50SiosX

Uncover new targets &amp; biomarkers, accelerate clinical trials &amp; more, w/the deepest multimodal dataset for #OncologyResearch &amp; development.  
• Longitudinal lifetime-consented clinical data  
• Tumor &amp; Germline DNA  
• Tumor RNA  
• Digital pathology  
ow.ly/hswq50SiosX
AsterInsights (@asterinsights) 's Twitter Profile Photo

New #CancerResearch from our #ORIEN Genitourinary RIG led by Dr. Sumati Gupta, characterizes inherited urothelial cancer risk & emphasizes the significance of comprehensive germline testing in patients w/non-bladder primary disease sites. ascopubs.org/doi/10.1200/PO… #UrothelialCancer

New #CancerResearch from our #ORIEN Genitourinary RIG led by Dr. Sumati Gupta, characterizes inherited urothelial cancer risk &amp; emphasizes the significance of comprehensive germline testing in patients w/non-bladder primary disease sites. ascopubs.org/doi/10.1200/PO… #UrothelialCancer
AsterInsights (@asterinsights) 's Twitter Profile Photo

Excited to host Dr. Kimryn Rathmell, NCI Director, as our keynote speaker & Dr. Richard Pazdur, Director, FDA Oncology Center of Excellence, for a fireside chat at our 5th annual #ORIEN Scientific Summit this fall! #CollaborativeScience #OncologyResearch

Excited to host Dr. <a href="/KimrynRathmell/">Kimryn Rathmell</a>, NCI Director, as our keynote speaker &amp; Dr. Richard Pazdur, Director, <a href="/FDAOncology/">FDA Oncology</a> Center of Excellence, for a fireside chat at our 5th annual #ORIEN Scientific Summit this fall! #CollaborativeScience #OncologyResearch
AsterInsights (@asterinsights) 's Twitter Profile Photo

Industry partners often remark on the depth & quality of Aster data + our unique approach to collaborative research with #ORIEN cancer centers across the U.S. Learn from Dr. Eric Rubin how our solutions informed the early development strategy of Keytruda youtube.com/watch?v=dGDkzg…

Industry partners often remark on the depth &amp; quality of Aster data + our unique approach to collaborative research with #ORIEN cancer centers across the U.S. Learn from Dr. Eric Rubin how our solutions informed the early development strategy of Keytruda youtube.com/watch?v=dGDkzg…
Ahmad Tarhini (@atarhinimdphd) 's Twitter Profile Photo

Our latest published article |#Melanoma #tumor #microbiome & #TME #immunogenicity, response & resistance to #immunecheckpoint inhibitors | Great collaboration with Dan Spakowicz, AC Tan #ORIEN #IO team | ⁦Moffitt Cancer Center⁩ search.app/GSBjn2AWyemYXU…

Ohio State Medical Oncology (@ohiostatemedonc) 's Twitter Profile Photo

📝New publication from Dan Spakowicz & the exORIEN Consortium: The tumor #microbiome as a predictor of outcomes in patients with metastatic #melanoma treated with immune checkpoint inhibitors Ahmad Tarhini #ORIEN Cancer Research Communications doi.org/10.1158/2767-9…

Cancer Research Communications (@crc_aacr) 's Twitter Profile Photo

#ICYMI: The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors, by Caroline E. Dravillas et al. bit.ly/3Su8pNj Dan Spakowicz Ahmad Tarhini Ohio State Medical Oncology The James Moffitt Cancer Center #openaccess

#ICYMI: The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors, by Caroline E. Dravillas et al.
bit.ly/3Su8pNj
<a href="/dspakowicz/">Dan Spakowicz</a> <a href="/ATarhiniMDPhD/">Ahmad Tarhini</a> <a href="/OhioStateMedOnc/">Ohio State Medical Oncology</a> <a href="/OSUCCC_James/">The James</a> <a href="/MoffittNews/">Moffitt Cancer Center</a> #openaccess
AsterInsights (@asterinsights) 's Twitter Profile Photo

On #WorldLungCancerDay, we're proud to be a part of the early development & indication expansion of pembrolizumab, a revolutionary treatment option for many types of cancer, incl. advanced #NSCLC. Our partnerships w/industry, academic cancer centers & patients make this possible.

AsterInsights (@asterinsights) 's Twitter Profile Photo

We collaborate with experts at the nation's top cancer centers to study real-world patient data retrospectively & prospectively. These unique pan-cancer insights accelerate oncology discovery & development and advance cancer care. #CancerResearch #RWD asterinsights.com/solutions/

We collaborate with experts at the nation's top cancer centers to study real-world patient data retrospectively &amp; prospectively. These unique pan-cancer insights accelerate oncology discovery &amp; development and advance cancer care. #CancerResearch #RWD asterinsights.com/solutions/
AsterInsights (@asterinsights) 's Twitter Profile Photo

Scientists across #ORIEN are continually innovating & studying a broad range of topics such as tumor microbiomes, #immuno-oncology, inherited risks, #HealthEquity, #DataScience, #Sarcoma, #BreastCancer, #GI, Thyroid #cancers, and more. asterinsights.com/research/publi…

Scientists across #ORIEN are continually innovating &amp; studying a broad range of topics such as tumor microbiomes, #immuno-oncology, inherited risks, #HealthEquity, #DataScience, #Sarcoma, #BreastCancer, #GI, Thyroid #cancers, and more.  asterinsights.com/research/publi…
AsterInsights (@asterinsights) 's Twitter Profile Photo

Longitudinal clinical data w/hundreds of data elements + rich molecular data custom built for oncology discovery + digital pathology images w/AI-powered insights = an unmatched research solution for discovery & clinical development. asterinsights.com/aster-avatar/ #OncologyResearch #RWD

Longitudinal clinical data w/hundreds of data elements + rich molecular data custom built for oncology discovery + digital pathology images w/AI-powered insights = an unmatched research solution for discovery &amp; clinical development. asterinsights.com/aster-avatar/ #OncologyResearch #RWD
AsterInsights (@asterinsights) 's Twitter Profile Photo

September is Prostate Cancer Awareness Month – Scientists across ORIEN and Aster Insights are working together, armed with Avatar clinicogenomic data, to unlock the complexities of this disease and improve outcomes for men needing novel therapeutic options. G. Daniel Grass MD, PhD

September is Prostate Cancer Awareness Month – Scientists across ORIEN and Aster Insights are working together, armed with Avatar clinicogenomic data, to unlock the complexities of this disease and improve outcomes for men needing novel therapeutic options. <a href="/gdgrass/">G. Daniel Grass MD, PhD</a>